好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Thyroid Autoimmune Adverse Events in Patients Treated with Alemtuzumab for Relapsing-remitting Multiple Sclerosis: Four-year Follow-up of the CARE-MS Studies
Multiple Sclerosis
(-)
199
Authors/Disclosures
Cary L. Twyman, MD, FAAN
PRESENTER 		No disclosure on file
David C. Spencer, MD, FAAN Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuiticals. Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Spencer has received research support from NIH. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative 好色先生 Concepts.
No disclosure on file
No disclosure on file
David H. Margolin, MD, PhD (Genzyme Corporation) Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Colin Dayan Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Provention Bio. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli-Lilly. Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Provention Bio. Colin Dayan has received intellectual property interests from a discovery or technology relating to health care.